These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 5047860)

  • 1. Aldehyde dehydrogenase and monoamine oxidase in the striatum of cats with nigrostriatal lesions.
    Duncan RJ; Sourkes TL; Boucher R; Poirier LJ; Roberge A
    J Neurochem; 1972 Aug; 19(8):2007-10. PubMed ID: 5047860
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoamine oxidase and aldehyde dehydrogenase activity in the striatum of rats after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Agid Y; Javoy F; Youdim MB
    Br J Pharmacol; 1973 May; 48(1):175-8. PubMed ID: 4724190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholamine-metabolizing enzyme activity in the nigrostriatal system.
    Francis A; Whittemore R; Jeffery DR; Pearce LB; Roth JA
    Biochem Pharmacol; 1987 Jul; 36(13):2229-31. PubMed ID: 3111478
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of amines in the striatum in monkeys with nigral lesions. The disposition, biosynthesis and metabolites of [3H]dopamine and [14C]serotonin in the striatum.
    Goldstein M; Anagnoste B; Battista AF; Owen WS; Nakatani S
    J Neurochem; 1969 Apr; 16(4):645-53. PubMed ID: 4976670
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of nigral and raphé lesions on the catechol-O-methyl transferase and monoamine oxidase activities in the rat striatum.
    Marsden CA; Broch OJ; Guldberg HC
    Eur J Pharmacol; 1972 Jul; 19(1):35-42. PubMed ID: 4558780
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic selegiline administration transiently decreases tyrosine hydroxylase activity and mRNA in the rat nigrostriatal pathway.
    Vrana SL; Azzaro AJ; Vrana KE
    Mol Pharmacol; 1992 May; 41(5):839-44. PubMed ID: 1350320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of Monoamine Oxidase in the Nigrostriatal System at Presymptomatic and Early Symptomatic Stages of Parkinsonism in Mice.
    Khakimova GR; Kozina EA; Buneeva OA; Aksenova LN; Medvedev AE; Ugryumov MV
    Bull Exp Biol Med; 2015 Aug; 159(4):456-8. PubMed ID: 26388575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of aldehyde dehydrogenase, aldehyde reductase, and acetylcholine esterase in striatum of rats bearing electrolytic lesions of the medial forebrain bundle.
    Duncan RJ; Sourkes TL; Dubrovsky BO; Quik M
    J Neurochem; 1975 Jan; 24(1):143-7. PubMed ID: 234146
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of brain lesions and of harmaline on the DOPA decarboxylase activity in the striatum of the cat.
    Lancaster G; Larochelle L; Bédard P; Missala K; Sourkes TL; Poirier LJ
    J Neurol Sci; 1970 Sep; 11(3):265-74. PubMed ID: 5505688
    [No Abstract]   [Full Text] [Related]  

  • 10. Locomotor activity and speed of movements in relation to monoamine-acting drugs.
    Hassler R; Wagner A
    Int J Neurol; 1975; 10(1-4):80-97. PubMed ID: 126971
    [No Abstract]   [Full Text] [Related]  

  • 11. The in vivo effect of tropolone on dopamine metabolism and the catechol-O-methyl transferase activity in the striatum of the rat.
    Broch OJ
    Acta Pharmacol Toxicol (Copenh); 1972; 31(3):217-25. PubMed ID: 5068602
    [No Abstract]   [Full Text] [Related]  

  • 12. Injection of 6-hydroxydopamine and hydrogen peroxide into the substantia nigra and lateral ventricle of the cat: specific and nonspecific effects on striatal biogenic amines.
    Stahl SM; Daniels AC; Derda D; Spehlmann R
    J Neurochem; 1975 Jan; 24(1):165-72. PubMed ID: 1110359
    [No Abstract]   [Full Text] [Related]  

  • 13. Activation of monoamine oxidase and inhibition of aldehyde dehydrogenase by reserpine.
    Youdim MB; Sandler M
    Eur J Pharmacol; 1968 Aug; 4(1):105-7. PubMed ID: 5680364
    [No Abstract]   [Full Text] [Related]  

  • 14. [Etiology and pathogenesis of idiopathic Parkinsonism: a model].
    Laplante M; Tran-Manh N
    Agressologie; 1973; 14(5):287-307. PubMed ID: 4153210
    [No Abstract]   [Full Text] [Related]  

  • 15. The susceptibility to acetylcholine and dopamine in the caudate nucleus of cats with chronic nigrostriatal lesions.
    Sphelmann R
    Trans Am Neurol Assoc; 1974; 99():255-7. PubMed ID: 4156892
    [No Abstract]   [Full Text] [Related]  

  • 16. Alterations in ingestive behaviour following basal ganglia stimulation in cats.
    Gravante G; Sorbera F; Sabatino M; La Grutta V
    Acta Neurol (Napoli); 1985 Oct; 7(5):381-93. PubMed ID: 4061149
    [No Abstract]   [Full Text] [Related]  

  • 17. Nigro-striatal pathway: stimulation-evoked release of ( 3 H)dopamine from caudate nucleus.
    Voigtlander PF; Moore KE
    Brain Res; 1971 Dec; 35(2):580-3. PubMed ID: 5135554
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopaminergic neurons in explants of substantia nigra in culture.
    Coyle JT; Jacobowitz D; Klein D; Axelrod J
    J Neurobiol; 1973; 4(5):461-70. PubMed ID: 4147763
    [No Abstract]   [Full Text] [Related]  

  • 19. Electrical stimulation of the substantia nigra and changes of 2-phenylethylamine synthesis in the rat striatum.
    Juorio AV; Paterson IA; Zhu MY; Matte G
    J Neurochem; 1991 Jan; 56(1):213-20. PubMed ID: 1670953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons.
    Demarest KT; Smith DJ; Azzaro AJ
    J Pharmacol Exp Ther; 1980 Nov; 215(2):461-8. PubMed ID: 7441510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.